4//SEC Filing
LIDGARD GRAHAM PETER 4
Accession 0001209191-21-014495
CIK 0001124140other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:24 PM ET
Size
11.0 KB
Accession
0001209191-21-014495
Insider Transaction Report
Form 4
LIDGARD GRAHAM PETER
SVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-23+11,575→ 47,171 total - Sale
Common Stock
2021-02-24$136.30/sh−5,842$796,265→ 41,329 total - Exercise/Conversion
Restricted Stock Units
2021-02-23−11,575→ 0 total→ Common Stock (11,575 underlying)
Holdings
- 12,725(indirect: By 401(k))
Common Stock
- 4,673(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents shares of common stock received upon vesting of a restricted stock unit award.
- [F2]Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 23, 2021.
- [F3]In addition to the shares of Common Stock reported on this Form 4, which total 58,727 shares, Mr. Lidgard also holds, in the aggregate, an additional 119,893 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- [F4]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F5]Represents a restricted stock unit award that partially vested on February 23, 2021. The restricted stock units vest in four equal annual installments beginning on February 23, 2018.
Documents
Issuer
EXACT SCIENCES CORP
CIK 0001124140
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001216274
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 7:24 PM ET
- Size
- 11.0 KB